@cimaragroup.bsky.social
Consortium for Intracranial Metastasis Academic Research (CIMARa). Directors: Carey Anders, MD of Duke University and Hussein Tawbi, MD of MD Anderson.
Anyone with an interest in CNS metastasis research – providers, researchers, advocates – can join us. For more information or to join the group, please email us. You can also visit our website, still in development: sites.google.com/view/cimarad....
06.06.2025 14:00 — 👍 0 🔁 0 💬 0 📌 0
CIMARa has 4 goals:
1) Establish an infrastructure to enhance discovery & development of #brainmetstherapies
2) Provide a network of experts to advance & implement clinical trials for patients with #brainmets
3) Harmonize study end-points
4) Develop a common forum for discussion
Hello! Formally introducing CIMARa. Led by CareyAnders
(@dukemets.bsky.social) and @HTawbi_MD
(@mdanderson.bsky.social), we are physicians, scientists, non-profits & advocates who share the goal of improving outcomes for patients with #brainmets through awareness & coordination of research.
Metastatic brain tumors are different than primary brain tumors. Not only are they more common, they're not actually brain cancer. The cancer is still the primary cancer - lung, breast, or others - but that cancer is now in the brain.
06.06.2025 13:03 — 👍 1 🔁 1 💬 0 📌 0
Palliative care is about providing relief and preventing suffering at any age or stage of illness. Palliative care experts partner with patients, their families, and their medical teams to meet your personalized goals.
05.06.2025 13:18 — 👍 1 🔁 1 💬 0 📌 0
A recent study by Duke Center for Brain and Spine Metastasis researchers found a nearly two-fold increase in the risk of radiation necrosis among patients with brain metastases receiving immunotherapies within four weeks of radiosurgery.
A recent study by DCBSM researchers found a nearly two-fold increase in the risk of radiation necrosis among patients with brain metastases receiving immunotherapies within four weeks of radiosurgery.
Learn more: neurosurgery.duke.edu/news/therapy...
#OncSky #MedSky #AcademicSky
LITT (laser interstitial thermal therapy) is a minimally invasive surgical technique. LITT can be effective for recurrent brain tumors, radiation necrosis, and tumors deep within the brain that would otherwise be inoperable.
LITT (laser interstitial thermal therapy) uses a laser to destroy unhealthy brain tissue, including new & recurrent brain tumors & radiation necrosis.
LITT is minimally invasive - the opening in the scalp is only about as big as a pencil eraser.
Learn more: www.dukehealth.org/treatments/n...
Among patients with lung cancer, about 16-20% develop brain metastases.
Did you know? Among patients with lung cancer, about 16-20 percent develop brain metastases. Risk of brain mets is highest in SCLC, EGFR, and ALK positive lung cancers.
#OncSky #MedSky
Curious about CIMARa and what we do? Read our white paper, recently published in Neuro-Oncology Advances! Physicians, researchers, and advocates focused on brain metastasis, including leptomeningeal disease, are welcome to join.
pubmed.ncbi.nlm.nih.gov/40276376/
